WFIKKN2 is secreted and elevated in blood plasma of HER2-positive breast cancer patients – implications in cancer surveillance and recurrence monitoring

Abstract Current methods for post-treatment cancer surveillance and recurrence monitoring rely mainly on biophysical imaging methods like CT and MRI. Limitations associated with these approaches include risk of radiation, high cost and sophistication in operation. Minimally invasive blood test is a...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Amir Sabbaghian, Fei Xie, Xiao Fang Wang, Zhen Yang, Ming Chen Zhang, Ting Gang Chew, Shu Wang, Yoon Pin Lim
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2025-11-01
Serie:	Biomarker Research
Soggetti:	WFIKKN2 HER2-positive breast cancer Biomarker Detection Surveillance
Accesso online:	https://doi.org/10.1186/s40364-025-00853-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!